Methods of Embryo Selection (improved)

Rationale Behind Embryo Selection Methods
  • Employing specific methods for embryo selection based on scientific rationale in reproductive medicine.

Lecture Overview
  • Overview of key topics discussed in the lecture:

    • Development of a zygote to the blastocyst stage

    • Visual cues to assess embryo 'quality'

    • Clinical decisions made for embryo transfer on a specific day of development

    • Temporal development of embryos using time-lapse imaging

    • Pre-implantation Genetic Testing (PGT) and Embryo biopsy

Morphology Assessment

Embryo Development & Morphology

  • Embryo Morphology Scoring:

    • Commonly used method for assessing which embryos are chosen for transfer or freezing.

    • Advantages:

    • Quick

    • Easy

    • Non-invasive assessments

    • Disadvantages:

    • Not always reliable but considered good indicators, especially for freezing purposes.

National External Quality Assessment Scheme - NEQAS

Module Breakdown

  • Parameters for assessment:

    • Sperm Motility: 92%92\% Match (Grade 1.21.2)

    • Sperm Morphology: 87%87\% Match (Grade 1.61.6)

    • Embryos from Patients:

    • Patient 11: 82%82\% Match (Grade 1.81.8)

    • Patient 22: 84%84\% Match (Grade 2.52.5)

    • Patient 33: 89%89\% Match (Grade 1.51.5)

    • Patient 44: 86%86\% Match (Grade 1.51.5)

  • Grade Ranges:

    • 1.0−1.51.0-1.5: Very good

    • 1.6−2.51.6-2.5: Good

    • 2.6−3.02.6-3.0: Satisfactory

  • Match \% Explanation:

    • The Match parameter describes the correlation of your results with reference values, assessing the quality of outcomes.

Development Timeline of Embryos

Temporal Development of an Embryo

  • Day 11: Zygote forms within 16−2016-20 hours

  • Day 22: Transitions to 22-cell stage (24−3024-30h)

  • Day 22: Reaches 44-cell stage (4848h)

  • Day 33: Becomes 88-cell stage (66−7266-72h)

  • Day 44: Morula stage (9090h)

  • Day 55:

    • Early Blastocyst (9696h)

    • Expanding Blastocyst (114114h)

    • Fully Expanded Blastocyst (120120h)

  • Statistical Prediction:

    • Prediction of producing a full-term birth: 50%50\% based on development stage.

Pronuclear Morphology & Abnormality Causes
  • 22PN Zygote: Represents proper fertilisation with two pronuclei.

  • Abnormalities can arise from:

    • Chemical or physical stress causing parthenogenesis or non-synchronous appearance of pronuclei.

    • Retention of polar bodies in IVF and ICSI cases and polyspermy phenomena.

Pronuclear Nucleoli: A Predictor of Embryo Quality?
  • Nucleoli patterning has been proposed to determine quality, suggesting development occurs within a narrow window of time (James et al. 20072007).

Embryo Morphology Scoring

Day 22 & Day 33 Scoring

  • Day 22 Assessment: Embryos should ideally have 2−42-4 cells;

  • Day 33 Assessment: Should contain 7−97-9 cells.

Blastomere Characteristics

Size and Fragmentation Assessment

  • Regularity and Size: Regularity in blastomere size significantly correlates with increased pregnancy outcomes (Hardarson et al., 20012001; Holte et al., 20072007).

  • Fragmentation:

    • Up to 75%75\% of in vitro embryos show fragmentation, impacting implantation.

    • Over 15%15\% fragmentation can impair development; 90%90\% of live birth embryos exhibit less than 15%15\% fragmentation (Alikani, 20072007).

  • Influencing Factors: Apoptosis, culture conditions, maternal age, and hereditary factors may contribute.

Clinical Considerations for Embryo Quality and Transfer
  • Factors Influencing Decisions:

    • Quality of embryos vs. developmental rate

    • Previous IVF outcomes influencing future decisions

    • Number of embryos available for transfer

    • Endometrial synchrony may influence timing of transfer (Day 33 vs. Day 55).

    • Genetic screening needs and patient preferences.

Blastocyst Development and Scoring

Scoring on Day 55

  • Expansion Status: Ranges (11 to 66):

    • 11: Early Blastocyst (blastocoel < half volume)

    • 22: Blastocyst (blastocoel > half volume)

    • 33: Full Blastocyst (blastocoel fills embryo)

    • 44: Expanded Blastocyst (blastocoel > volume of embryo)

    • 55: Hatching Blastocyst (trophectoderm herniates through zona pellucida)

    • 66: Hatched Blastocyst (evacuated zona pellucida).

Temporal Development: Time-Lapse Imaging (TLI)
  • Systems Used: Various time-lapse imaging systems (Embryoscope, EEVA, etc.) capture images every 5−105-10 minutes.

    • Detailed evaluations of developmental timings contribute to understanding embryo viability and potential.

TLI Advantages and Disadvantages

Advantages:

  • Improved predictions of blastocyst potential and embryo vitality through continuous monitoring.

Disadvantages:

  • Possibility of surrendering viable embryos as culture selects against those with lower developmental potential.

  • Studies suggested differing implantation success between Day 33 transfers and Day 55 selection (Yang et al., 20182018).

AI for Morphokinetic Scoring

Implementation:

  • Automation and improved selection of embryos from TLI data with AI. Potentially offering better predictive capabilities compared to traditional methods (Diakiw 20222022; Sawada et al. 20212021).

Pre-Implantation Genetic Testing (PGT)
  • Types of tests:

    • PGT-A: Aneuploidy Screening

    • PGT-M/SR: Mendelian Disorders Diagnosis

Evolution of PGT: Methods

  • Biopsy Techniques:

    • Polar Body Biopsy

    • Cleavage Stage Biopsy (22PN, 88-cell stages)

    • Blastocyst Biopsy (5−105-10 cells).

PGT Applications and Implications

Advantages:

  • Reduces chances of aneuploidy-related implantation failures.

  • Facilitated single embryo transfers, improving outcomes for patients with multiple clinical complexities.

Disadvantages:

  • Cost, risk of damaging embryos during biopsy, and complications from mosaicism remain challenges.

PGT Evidence
  • Need for further research; insufficient high-quality evidence for an increase in successful live births when employing PGT. Potential risks associated with mosaicism within embryos need clarification according to more recent studies (Cornelisse et al., 20202020).